A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday. The drug — ‘prussian blue’ insoluble formulations — was developed under the Technology Development Fund (TDF). The TDF was launched primarily for creating an ecosystem for promoting self-reliance by building indigenous state-of-the-art systems for defence application. In a statement, the defence ministry said the drug has been developed by the industry based on the technology of Institute of Nuclear…
Read MoreApproval granted for procurement of Weapons for Armed Forces and Indian Coast Guard
